EUVIMEDEUVIMED entdecken
Crossref

Best Practices and a Business Case for Surgical Site Infection Prevention

Minji Kang, Maria E Andrew, Akil Farishta, Sarah C Oltmann, Pranavi V Sreeramoju

AORN Journal · 2023-05 · 117 (5) · 277-290

DOI: 10.1002/aorn.13912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AORN Journal, online erschienen am 27.04.2023. Verfasst von Minji Kang und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Surgical Wound Infection, Staphylococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surgical site infections (SSIs) can be costly and result in prolonged hospital stays; readmissions; and additional diagnostic tests, therapeutic antibiotic treatments, and surgical procedures. Evidence‐based practices for preventing SSIs include environmental cleaning; instrument cleaning, decontamination, and sterilization; preoperative bathing; preoperative Staphylococcus aureus decolonization; intraoperative antimicrobial prophylaxis; hand hygiene; and surgical hand antisepsis. Strong partnerships among infection prevention personnel, perioperative nurses, surgeons, and anesthesia professionals may enhance perioperative infection prevention. Facility and physician‐specific SSI rates should be reported to physicians and frontline personnel in a timely, accessible manner. Together with costs associated with SSIs, these data help determine the success of an infection prevention program. Leaders can develop a comprehensive business case proposal for perioperative infection prevention programs. The proposal should describe the need for the program and anticipated return on investment; it also should focus on the goal of decreasing SSIs by establishing metrics for assessing outcomes and addressing barriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surgical Wound InfectionStaphylococcal InfectionsHumansAnti-Bacterial AgentsStaphylococcus aureusAntisepsis

Stichwörter der Autor:innen

business case proposalcost-benefit analysishealth care-associated infectioninfection preventionsurgical site infection (SSI)

Substanzen

Anti-Bacterial Agents

Zitieren

APA

Kang, M., Andrew, M. E., Farishta, A., Oltmann, S. C., & Sreeramoju, P. V. (2023). Best Practices and a Business Case for Surgical Site Infection Prevention. AORN Journal, 117(5), 277-290. https://doi.org/10.1002/aorn.13912

Vancouver

Kang M, Andrew ME, Farishta A, Oltmann SC, Sreeramoju PV. Best Practices and a Business Case for Surgical Site Infection Prevention. AORN Journal. 2023;117(5):277-290. doi:10.1002/aorn.13912

BibTeX
@article{Kang2023,
  author = {Kang, Minji and Andrew, Maria E and Farishta, Akil and Oltmann, Sarah C and Sreeramoju, Pranavi V},
  title = {Best Practices and a Business Case for Surgical Site Infection Prevention},
  journal = {AORN Journal},
  year = {2023},
  volume = {117},
  number = {5},
  pages = {277--290},
  doi = {10.1002/aorn.13912}
}
Kostenlos starten →